GB0325173D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0325173D0
GB0325173D0 GBGB0325173.3A GB0325173A GB0325173D0 GB 0325173 D0 GB0325173 D0 GB 0325173D0 GB 0325173 A GB0325173 A GB 0325173A GB 0325173 D0 GB0325173 D0 GB 0325173D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0325173.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0325173.3A priority Critical patent/GB0325173D0/en
Publication of GB0325173D0 publication Critical patent/GB0325173D0/en
Priority to PCT/EP2004/012151 priority patent/WO2005049041A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0325173.3A 2003-10-28 2003-10-28 Organic compounds Ceased GB0325173D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0325173.3A GB0325173D0 (en) 2003-10-28 2003-10-28 Organic compounds
PCT/EP2004/012151 WO2005049041A1 (fr) 2003-10-28 2004-10-27 Combinaisons comportant des antagonistes de recepteur ampa pour le traitement de troubles d'anxiete

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0325173.3A GB0325173D0 (en) 2003-10-28 2003-10-28 Organic compounds

Publications (1)

Publication Number Publication Date
GB0325173D0 true GB0325173D0 (en) 2003-12-03

Family

ID=29725527

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0325173.3A Ceased GB0325173D0 (en) 2003-10-28 2003-10-28 Organic compounds

Country Status (2)

Country Link
GB (1) GB0325173D0 (fr)
WO (1) WO2005049041A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2690110A1 (fr) * 2007-07-13 2009-01-22 Eisai R&D Management Co., Ltd. Anatagonistes des recepteurs ampa contre la douleur neuropathique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934326B1 (fr) * 1996-10-24 2006-05-03 Novartis AG Acides aminoalcanophosphoniques substitues

Also Published As

Publication number Publication date
WO2005049041A1 (fr) 2005-06-02

Similar Documents

Publication Publication Date Title
GB0325830D0 (en) Organic compounds
GB0301259D0 (en) Organic compounds
GB0308335D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
GB0306715D0 (en) Organic compounds
GB0302876D0 (en) Organic compounds
GB0307860D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0301471D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0303506D0 (en) Organic compounds
GB0307440D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0325390D0 (en) Organic compounds
GB0325173D0 (en) Organic compounds
GB0307277D0 (en) Organic compounds
GB0314697D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
GB0301692D0 (en) Organic compounds
GB0303323D0 (en) Organic compounds
GB0300591D0 (en) Organic compounds
GB0301561D0 (en) Organic compounds
GB0300590D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)